Literature DB >> 31351673

Genotype-phenotype associations in Fanconi anemia: A literature review.

Moisés O Fiesco-Roa1, Neelam Giri2, Lisa J McReynolds3, Ana F Best4, Blanche P Alter5.   

Abstract

Fanconi anemia (FA) is a genomic instability syndrome with predisposition to congenital abnormalities, bone marrow failure, and cancer. Classical and most frequent congenital abnormalities include all those seen in VACTERL-H association and those described under the PHENOS acronym. Pathogenic variants in at least 22 genes are associated with FA, which code for proteins that comprise the FA/BRCA DNA repair pathway. We reviewed 187 publications and 1101 cases of FA in which the gene or complementation group was identified and analyzed those in whom physical findings were sought. We conducted genotype-phenotype analyses considering the specific gene, the location in the FA/BRCA DNA repair pathway, and the type of variant (null or hypomorphic) as exposures. The outcomes were the presence of any physical abnormality or specific categories of abnormalities. Seventy-nine percent of the patients had at least one physical abnormality. Pathogenic variants in FANCB, FANCD2, the ID complex and downstream genes were associated with several specific anomalies. Patients with biallelic or hemizygous null variants had a higher proportion of at least one abnormality, renal malformations, microcephaly, short stature and the combination of VACTERL-H compared with those with hypomorphic genotypes. VACTERL-H alone or in combination with PHENOS is highly associated with FA, but the absence of those features does not rule out the diagnosis of FA. Published by Elsevier Ltd.

Entities:  

Keywords:  Congenital abnormality; Fanconi anemia; Gene; Genotype-phenotype association; PHENOS; VACTERL-H

Year:  2019        PMID: 31351673      PMCID: PMC6730648          DOI: 10.1016/j.blre.2019.100589

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  36 in total

1.  Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Authors:  Lisa J McReynolds; Youjin Wang; Ashley S Thompson; Bari J Ballew; Jung Kim; Blanche P Alter; Belynda Hicks; Bin Zhu; Kristine Jones; Stephen R Spellman; Tao Wang; Stephanie J Lee; Sharon A Savage; Shahinaz M Gadalla
Journal:  Biol Blood Marrow Transplant       Date:  2020-01-23       Impact factor: 5.742

2.  Fanconi Anemia: A Syndrome of Anemia and Skeletal Malformations Progressing to a Gene Network Involved in Genomic Stability and Malignant Disease.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2020-10-22

3.  Phenotypic Characteristics and Copy Number Variants in a Cohort of Colombian Patients with VACTERL Association.

Authors:  Olga M Moreno; Ana I Sánchez; Angélica Herreño; Gustavo Giraldo; Fernando Suárez; Juan Carlos Prieto; Ana Shaia Clavijo; Mercedes Olaya; Yaris Vargas; Javier Benítez; Jordi Surallés; Adriana Rojas
Journal:  Mol Syndromol       Date:  2020-11-11

4.  Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).

Authors:  Lisa J McReynolds; Kajal Biswas; Neelam Giri; Shyam K Sharan; Blanche P Alter
Journal:  Cancer Genet       Date:  2021-10-04

5.  Spectrum of Germline Mutations Within Fanconi Anemia-Associated Genes Across Populations of Varying Ancestry.

Authors:  Sock Hoai Chan; Ying Ni; Shao-Tzu Li; Jing Xian Teo; Nur Diana Binte Ishak; Weng Khong Lim; Joanne Ngeow
Journal:  JNCI Cancer Spectr       Date:  2021-01-05

Review 6.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

Review 7.  Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.

Authors:  Oriana Miltiadous; Ming Hou; James B Bussel
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

8.  Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes.

Authors:  Joseph H Oved; Daria V Babushok; Michele P Lambert; Nicole Wolfset; M Anna Kowalska; Mortimer Poncz; Konrad J Karczewski; Timothy S Olson
Journal:  Blood Adv       Date:  2020-10-27

9.  A safe fix for alcohol-derived DNA damage.

Authors:  Irene Gallina; Julien P Duxin
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

10.  Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.

Authors:  Rex H Lee; Hyunseok Kang; Sue S Yom; Agata Smogorzewska; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.